Steven Cohen’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.1M Buy
1,257,897
+267,617
+27% +$9.1M 0.04% 573
2026
Q2
$31.4M Sell
990,280
-111,991
-10% -$3.31M 0.03% 632
2026
Q1
$33.2M Buy
1,102,271
+598,120
+119% +$19.3M 0.04% 555
2025
Q4
$17.5M Sell
504,151
-31,680
-6% -$1.12M 0.02% 986
2025
Q3
$19.5M Sell
535,831
-284,594
-35% -$9.7M 0.03% 560
2025
Q2
$25.7M Buy
820,425
+192,133
+31% +$5.97M 0.05% 418
2025
Q1
$18.6M Buy
628,292
+224,988
+56% +$6.75M 0.04% 462
2024
Q4
$11.9M Buy
+403,304
New +$12.8M 0.03% 637
2022
Q2
– Sell
-407,058
Closed -$12.2M – 1500
2022
Q1
$12.2M Buy
407,058
+394,658
+3,183% +$10M 0.05% 460
2021
Q4
$425K Sell
12,400
-136,600
-92% -$4.95M ﹤0.01% 980
2021
Q3
$5.52M Buy
149,000
+76,100
+104% +$2.57M 0.02% 641
2021
Q2
$2.85M Buy
+72,900
New +$2.81M 0.01% 691

Other funds holding IMCR

Steven Cohen's IMCR Position: Q3 2026 in Review

Steven Cohen increased its Immunocore (IMCR) stake by 27% in Q3 2026, buying an estimated $9.1M and bringing the position to 1,257,897 shares worth $38.1M. The position accounts for 0.04% of the portfolio, ranked #573.

Steven Cohen first reported a position in IMCR in Q2 2021 and has held it in 12 quarters since. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • Steven Cohen held 1,257,897 shares of Immunocore worth $38.1M as of Q3 2026.
  • Steven Cohen bought 267,617 Immunocore shares in Q3 2026, an estimated $9.1M.
  • Immunocore made up 0.04% of Steven Cohen's portfolio in Q3 2026, its #573 holding.
  • Steven Cohen first reported a position in Immunocore in Q2 2021 and has held it in 12 quarters since.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.